Considerations on markers of hepatitis B, C and HIV as indicators of risk behaviour in intravenous drug users.
Mele
A
A
Biancolilli
V
V
D'Argenio
P
P
Sagliocca
L
L
D000163:Acquired Immunodeficiency Syndrome / Q000635:transmission; D000293:Adolescent; D000328:Adult; D015415:Biomarkers; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015483:HIV Antibodies / Q000302:isolation & purification*; D015497:HIV-1; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000302:isolation & purification*; D006510:Hepatitis B Antibodies / Q000032:analysis*; D006511:Hepatitis B Antigens / Q000032:analysis*; D018937:Hepatitis C Antibodies; D006801:Humans; D007558:Italy; D008297:Male; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous
D015415:Biomarkers; D015483:HIV Antibodies; D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D018937:Hepatitis C Antibodies